We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGPI:NASDAQMGP Ingredients, Inc. Analysis

Data as of 2026-05-31 - not real-time

$17.65

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MGPI is trading at $17.65, barely above the identified support of $17.51 and well below its 20‑day and 50‑day moving averages, with the 20‑day SMA (~$18.52) sitting above the current price, confirming a short‑term bearish bias. Momentum indicators are also negative, with an RSI of 39 and a bearish MACD histogram. Despite the weak price action, the stock offers a 2.72% dividend yield, though the payout ratio sits near 96% of earnings. The forward PE of about 8.4 and a price‑to‑book of 0.65 suggest the market is pricing the shares at a discount to book value. However, the DCF fair‑value estimate of $16.3 is below the current price, indicating limited upside from a discounted cash‑flow perspective.
The company posted a trailing loss per share of –$11.15 and a negative profit margin, while operating cash flow remains positive at roughly $84 million. Debt stands at $254 million against just $10 million of cash, yielding a debt‑to‑equity ratio above 40% and raising concerns about dividend sustainability. Volatility is elevated at nearly 39% over the past 30 days, though beta is modest at 0.58, reflecting lower systematic risk. Analyst consensus targets of $28–31 imply a potential upside, but the extreme greed market sentiment (FGI 94) may be inflating expectations. In the near term the stock faces downside pressure from bearish technicals and earnings weakness, while the dividend may be at risk if profitability does not improve. Over the medium to long horizon, a turnaround in earnings, the defensive consumer‑staple positioning, and the attractive dividend could support a rebound, provided the balance sheet is strengthened.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • price near technical support
  • bearish MACD and RSI indicating momentum weakness
  • high dividend payout ratio threatens sustainability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward earnings estimate turning positive
  • valuation discount to book value
  • analyst price targets suggest upside

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • defensive consumer staples exposure
  • potential balance sheet improvement through cash flow
  • dividend yield attractive if earnings recover

Key Metrics & Analysis

Financial Health

Revenue Growth-12.50%
Profit Margin-45.97%
P/E Ratio8.4
ROE-34.07%
ROA3.94%
Debt/Equity43.81
P/B Ratio0.6
Op. Cash Flow$83.8M
Free Cash Flow$44.8M

Technical Analysis

TrendBearish
RSI39.3
Support$17.51
Resistance$20.50
MA 20$18.52
MA 50$18.83
MA 200$23.26
MACDBearish
VolumeStable
Fear & Greed Index94.07

Valuation

Fair Value$16.32
Target Price$28.40
Upside/Downside60.91%
GradeFair
TypeValue
Dividend Yield2.72%

Risk Assessment

Beta0.58
Volatility38.87%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.